Mesangiolytic glomerulopathy is an uncommon complication of irradiation and chemotherapy of THP-COP [pirarubicin, cyclophosphamide (CPA), vincristin (VCR) 
Introduction

Since Warthin first reported autopsy findings in the kidneys of two leukemic patients who received irradiation therapy, radiation nephropathy has been known as an uncommon but potentially devastating complication of irradiation
. Early studies demonstrated that acceptable renal tolerance is [20] [21] [22] [23] . Although subsequent improvement in radiotherapeutic techniques has reduced the radiation dose to which kidneys are exposed, concurrent combination of chemotherapy and radiation may increase the incidence of radiation nephropathy (4) . Here, we describe a patient with gastric lymphoma who developed mesangiolytic glomerulopathy 7 months after radiotherapy and 10 months after chemotherapy.
Case Report
A 63-year-old man was referred to our clinic with mild renal insufficiency (serum creatinine, 1.62 T a b l e 1 . L a b o r a t o r y F i n d i n g s o Fig. 3 . (10) . It is generally accepted that some chemotherapeutic agents make the kidney more vulnerable to nephrotoxicity due to total body irradiation. The pathogenesis is still unclear. Tubulointerstitial nephritis (11, 12) , and membranous nephropathy (MN) (13) (19) . It has also been suggested that patients with collagen vascular diseases tolerate radiotherapy less well than other patients (20) . In the present case, the relationship among radiation, chemotherapy, and co-existing autoimmune diseases is unclear with respect to an increased tendency to induce renal injury. The incidence of complications in such a population appears to require the attention of oncologists.
t o f t h e g l o me r u l i s h o we d me s a n g i a l p r o l i f e r a t i o n a n d s e g me n t a l d o u b l e c o n t o u r o f t h e b a s e me n t me mb r a n e ( a r r o ws ) . Me s a n g i o l y s i s a n d ma s s i v e e x p a n s i o n o f t h e s u b e n d o t h e l i a l s p a c e ( * ) . A: P e r i o d i c a c i d -S c h i f f ( P AS ) s t a i n , × 2 0 0 , B : P e r i o d i c a c i d -me t h e n a mi n e s t a i n , × 2 0 0 . C: T u b u l o i n t e r s t i t i u m s h o ws f i b r o s i s . Az a n s t a i n , × 2 0 0 . D: T u b u l a r a t r o p h y , i n t e r s t i t i a l e d e ma , mi l d f i b r o s i s , a n d c h r o n i c i n f l a mma t o r y c e l l s ( ma i n l y l y mp h o c y t e s ) we r e s e e n . P AS s t a i n , × 2 0 0 . presence of continuous proteinuria. The clinical course of the patient is shown in
Discussion
Domagk described a 9-year-old girl who received abdominal irradiation for tuberculous mesenteric lymph nodes, and died 6 months later with symptoms of renal failure (5). The autopsied renal specimens showed glomerular hyalinization or thickening of Bowman's capsule, tubular atrophy or necrosis, and hyaline material in the arterial walls. Thus far, the histology of radiation nephropathy has been well characterized as including the following features: endothelial injury, mesangiolysis, and glomerular basement membrane expansion (6, 7). Irradiation produces toxic oxygen species, a process which is believed to be an important initiator of glomerular endothelial injury, followed by the detachment of the endothelium from the basement membrane and mesangiolysis (8). Mesangiolysis is characterized by the attenuation or dissolution of the matrix and by the degeneration of mesangial cells (8). In cases of radiation nephropathy, the endothelial damage occurs via the attachment of leukocytes to the glomerular capillary endothelium; the endothelial cells subsequently swell, which in turn leads to exudation of the plasma components (including leukocytes, erythrocytes, and platelets) into the subendothelial and mesangial compartments (8
Radiation nephropathy can be treated with angiotensin converting enzyme inhibitor (ACE-I) or ARB (18, 21) . It has been reported that oxidative stress plays a role in the radiation-induced late effect on organs in the development of radiation nephropathy (8, 22) . A novel signaling mechanism for angiotensin II has been identified involving the angiotensin II type I receptor-mediated production of superoxide generated by NADH/NADPH oxidase, and an increase in intracellular hydrogen peroxidase; it is therefore expected that ARB reflects inhibition of angiotensin II-mediated oxidative stress (23) . In an experimental model, angiotensin II receptor blocker protects the kidney from the development of radiation-induced fibrosis (21) . In the present case, the renal function and proteinuria levels remained stable for at least two years with the administration of ARB. The blockade of angiotensin II-mediated signaling may exert beneficial effects against the progression of chemotherapy and radiation-induced glomerular injury.
